NASDAQ
Ascendis Pharma A/S (ASND) has a revenue compound annual growth rate of 150.93% over 5 years and 55.97% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.